Topics

Biotech Stock News Bites: Evelo Biosciences (NASDAQ: $EVLO) Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights

09:55 EST 14 Feb 2020 | InvestorIdeas

February 14, 2020 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Biotechnology Stock News Bites- CAMBRIDGE, Mass.,Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, reported on the close yesterday, financial results and business highlights for the fourth quarter and full year 2019.

Original Article: Biotech Stock News Bites: Evelo Biosciences (NASDAQ: $EVLO) Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights

NEXT ARTICLE

More From BioPortfolio on "Biotech Stock News Bites: Evelo Biosciences (NASDAQ: $EVLO) Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...